What is the share price of Vaishali Pharma Ltd (VAISHALI) today?
The share price of VAISHALI as on 1st July 2025 is ₹11.51. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Vaishali Pharma Ltd (VAISHALI) share?
The past returns of Vaishali Pharma Ltd (VAISHALI) share are- Past 1 week: -6.07%
- Past 1 month: -8.59%
- Past 3 months: -0.60%
- Past 6 months: -35.41%
- Past 1 year: -26.88%
- Past 3 years: 39.94%
- Past 5 years: 139.79%
What are the peers or stocks similar to Vaishali Pharma Ltd (VAISHALI)?
The peers or stocks similar to Vaishali Pharma Ltd (VAISHALI) include:What is the market cap of Vaishali Pharma Ltd (VAISHALI) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vaishali Pharma Ltd (VAISHALI) is ₹123.38 Cr as of 1st July 2025.What is the 52 week high and low of Vaishali Pharma Ltd (VAISHALI) share?
The 52-week high of Vaishali Pharma Ltd (VAISHALI) is ₹24.91 and the 52-week low is ₹10.30.What is the PE and PB ratio of Vaishali Pharma Ltd (VAISHALI) stock?
The P/E (price-to-earnings) ratio of Vaishali Pharma Ltd (VAISHALI) is 152.32. The P/B (price-to-book) ratio is 2.88.Which sector does Vaishali Pharma Ltd (VAISHALI) belong to?
Vaishali Pharma Ltd (VAISHALI) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Vaishali Pharma Ltd (VAISHALI) shares?
You can directly buy Vaishali Pharma Ltd (VAISHALI) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Vaishali Pharma Ltd
VAISHALI Share Price
11.510.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
VAISHALI Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
VAISHALI Performance & Key Metrics
VAISHALI Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 152.32 | 2.88 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.48 | 6.57 | 0.80% |
VAISHALI Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
VAISHALI Company Profile
Vaishali Pharma Limited is a pharmaceutical company engaged in dealing in pharmaceutical formulations, active pharmaceutical ingredient (APIs), surgical products, veterinary supplements, and herbal and nutraceutical products
SUNPHARMA
PE Ratio
36.60
36.60
1Y Return
9.68%
9.68%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
23.22
23.22
1Y Return
2.47%
2.47%
Buy Reco %
74.19
74.19
TORNTPHARM
PE Ratio
60.51
60.51
1Y Return
22.85%
22.85%
Buy Reco %
75.00
75.00
DRREDDY
PE Ratio
18.79
18.79
1Y Return
0.48%
0.48%
Buy Reco %
55.17
55.17
ZYDUSLIFE
PE Ratio
22.29
22.29
1Y Return
7.25%
7.25%
Buy Reco %
46.43
46.43
VAISHALI Forecast
VAISHALI Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
VAISHALI
VAISHALI
Income
Balance Sheet
Cash Flow
Annual Normal View
VAISHALI Income Statement
VAISHALI Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 64.90 | 69.42 | 77.07 | 62.26 | 55.58 | 77.61 | 71.89 | 88.31 | 102.23 | 102.22 | ||||||||||
Raw Materials | 53.94 | 60.61 | 67.78 | 50.99 | 45.86 | 63.54 | 57.10 | 71.75 | 98.94 | 98.95 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Employee Cost | 1.59 | 2.04 | 2.13 | 1.27 | 1.19 | 1.36 | 1.30 | 1.40 | ||||||||||||
| Selling & Administrative Expenses | 2.38 | 2.97 | 2.15 | 2.62 | 1.94 | 4.06 | 4.28 | 3.44 | ||||||||||||
| Operating & Other expenses | 2.59 | -0.65 | 0.96 | 4.31 | 2.13 | -0.03 | -2.39 | 8.03 | ||||||||||||
EBITDA | 4.40 | 4.45 | 4.05 | 3.07 | 4.46 | 8.68 | 11.60 | 3.69 | 3.29 | 3.27 | ||||||||||
| Depreciation/Amortization | 0.28 | 0.25 | 0.27 | 0.44 | 0.43 | 0.46 | 0.50 | 0.51 | 0.49 | 0.48 | ||||||||||
| PBIT | 4.12 | 4.20 | 3.78 | 2.63 | 4.03 | 8.22 | 11.10 | 3.18 | 2.80 | 2.79 | ||||||||||
| Interest & Other Items | 3.10 | 2.85 | 2.66 | 2.56 | 2.63 | 2.49 | 2.26 | 2.27 | 1.58 | 1.58 | ||||||||||
| PBT | 1.02 | 1.35 | 1.12 | 0.07 | 1.40 | 5.73 | 8.84 | 0.91 | 1.22 | 1.21 | ||||||||||
| Taxes & Other Items | 0.33 | 0.55 | 0.42 | 0.05 | 0.36 | 1.70 | 2.24 | 0.21 | 0.41 | 0.40 | ||||||||||
| Net Income | 0.69 | 0.80 | 0.70 | 0.02 | 1.04 | 4.03 | 6.60 | 0.70 | 0.81 | 0.81 | ||||||||||
| EPS | 0.01 | 0.01 | 0.00 | 0.00 | 0.10 | 0.38 | 0.63 | 0.07 | 0.31 | 0.08 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
VAISHALI Company Updates
FY 2021FY 2021
Investor Presentation
Aug 6PDF
FY 2020FY 2020
Investor Presentation
May 28PDF
FY 2019FY 2019
FY 2018FY 2018
Investor Presentation
Jun 1PDF
Feb 26PDF
VAISHALI Stock Peers
VAISHALI Past Performance & Peer Comparison
VAISHALI Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Vaishali Pharma Ltd | 152.32 | 2.88 | — |
| Sun Pharmaceutical Industries Ltd | 36.60 | 5.96 | 0.96% |
| Cipla Ltd | 23.22 | 3.91 | 1.06% |
| Torrent Pharmaceuticals Ltd | 60.51 | 16.87 | 0.94% |
VAISHALI Stock Price Comparison
Compare VAISHALI with any stock or ETFCompare VAISHALI with any stock or ETF
VAISHALI
VAISHALI Holdings
VAISHALI Shareholdings
VAISHALI Promoter Holdings Trend
VAISHALI Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
VAISHALI Institutional Holdings Trend
VAISHALI Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 5.56%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
VAISHALI Shareholding Pattern
VAISHALI Shareholding Pattern
VAISHALI Shareholding History
VAISHALI Shareholding History
Foreign Institutions
smallcases containing VAISHALI stock
smallcases containing VAISHALI stock
Looks like this stock is not in any smallcase yet.
VAISHALI Events
VAISHALI Events
VAISHALI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
VAISHALI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
VAISHALI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
VAISHALI has not given any dividends in last 5 years
VAISHALI Dividends
VAISHALI Dividends
Hmm, looks like data is unavailable here. Please come back after some timeVAISHALI Stock News & Opinions
VAISHALI Stock News & Opinions
Articles & Videos
Earnings
Vaishali Pharma reports standalone net loss of Rs 4.29 crore in the March 2025 quarter
Net Loss of Vaishali Pharma reported to Rs 4.29 crore in the quarter ended March 2025 as against net loss of Rs 4.68 crore during the previous quarter ended March 2024. Sales declined 0.46% to Rs 32.25 crore in the quarter ended March 2025 as against Rs 32.40 crore during the previous quarter ended March 2024. For the full year,net profit rose 13.89% to Rs 0.82 crore in the year ended March 2025 as against Rs 0.72 crore during the previous year ended March 2024. Sales rose 14.78% to Rs 99.03 crore in the year ended March 2025 as against Rs 86.28 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales32.2532.40 0 99.0386.28 15 OPM %-18.73-20.93 -0.091.33 - PBDT-5.48-6.27 13 1.721.44 19 PBT-5.60-6.41 13 1.230.93 32 NP-4.29-4.68 8 0.820.72 14 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Vaishali Pharma to convene board meeting
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Vaishali Pharma standalone net profit declines 31.75% in the December 2024 quarter
Net profit of Vaishali Pharma declined 31.75% to Rs 1.44 crore in the quarter ended December 2024 as against Rs 2.11 crore during the previous quarter ended December 2023. Sales rose 0.04% to Rs 27.91 crore in the quarter ended December 2024 as against Rs 27.90 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales27.9127.90 0 OPM %4.8410.54 - PBDT2.042.98 -32 PBT1.922.86 -33 NP1.442.11 -32 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Vaishali Pharma announces board meeting date
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 6 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Vaishali Pharma to conduct board meeting
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Vaishali Pharma standalone net profit rises 15.88% in the September 2024 quarter
Net profit of Vaishali Pharma rose 15.88% to Rs 1.97 crore in the quarter ended September 2024 as against Rs 1.70 crore during the previous quarter ended September 2023. Sales rose 65.39% to Rs 20.79 crore in the quarter ended September 2024 as against Rs 12.57 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales20.7912.57 65 OPM %11.6421.08 - PBDT2.752.48 11 PBT2.632.36 11 NP1.971.70 16 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Vaishali Pharma to hold board meeting
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Vaishali Pharma schedules board meeting
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 10 October 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Vaishali Pharma to conduct board meeting
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 3 October 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Vaishali Pharma to hold board meeting
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 28 August 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 10.43%, vs industry avg of 10.2%
Over the last 5 years, market share stayed at 0.02%
Over the last 5 years, net income has grown at a yearly rate of 109.65%, vs industry avg of 20.11%